Liver Metastases — CapTem Plus Radioembolization for NET Liver Metastases
Citation(s)
UPCC04219 Phase 2 Study of Capecitabine-Temozolomide (CapTem) With Yttrium-90 Radioembolization in the Treatment of Patients With Unresectable Metastatic Grade 2 Neuroendocrine Tumors